ARYx Therapeutics
Fremont
About ARYx Therapeutics
ARYx is a product-driven pharmaceutical company with leading expertise and significant intellectual property in the area of retrometabolic drug design. They are focused on improving the safety of oral therapies for chronic disease.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 51 – 100
- Total funding: $138.7M
- Funding stage: IPO
- Last round: Post-IPO Debt (Aug 2010)
- Ticker: nasdaq:ARYX
- Website: aryx.com
- Phone: +1 510)585-2200
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Canonical: https://fsome.com/organization/aryx-therapeutics-1869625 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.